These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37522989)

  • 21. Efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer.
    Yokoyama T; Yoshida H; Makino H; Maruyama H; Suzuki S; Matsutani T; Matsushita A; Hirakata A; Sasajima K; Uchida E
    J Nippon Med Sch; 2012; 79(3):204-12. PubMed ID: 22791122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer.
    Tagawa T; Ito K; Fukuzawa K; Okamoto T; Yoshimura A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y
    Anticancer Res; 2017 Mar; 37(3):1413-1416. PubMed ID: 28314312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: a retrospective cohort study.
    Pu H; Chen Y; Shen R; Zhang Y; Yang D; Liu L; Dong X; Yang G
    World J Surg Oncol; 2023 Apr; 21(1):137. PubMed ID: 37101165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
    Li H; Zhao T; Ji X; Liang S; Wang Z; Yang Y; Yin J; Wang R
    Tumour Biol; 2016 Mar; 37(3):3535-42. PubMed ID: 26453118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastasectomy for recurrent or metastatic biliary tract cancers: A single center experience.
    Park I; Kim YS; Sym SJ; Ahn HK; Kim KK; Park YH; Lee JN; Shin DB
    Indian J Cancer; 2017; 54(1):57-62. PubMed ID: 29199665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience.
    Iwaki K; Yoh T; Nishino H; Nishio T; Koyama Y; Ogiso S; Ishii T; Kanai M; Hatano E
    Asian J Surg; 2024 Mar; 47(3):1383-1388. PubMed ID: 38160154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer.
    Isaka T; Ito H; Nakayama H; Yokose T; Saito H; Masuda M
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):778-786. PubMed ID: 34686875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.
    Kondo S; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Furuse J; Saito H; Tsuyuguchi T; Yamamoto M; Kayahara M; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Hirano S; Amano H; Miura F; ; ;
    J Hepatobiliary Pancreat Surg; 2008; 15(1):41-54. PubMed ID: 18274843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 32. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
    Utsumi M; Kitada K; Tokunaga N; Kato T; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    BMC Gastroenterol; 2021 Oct; 21(1):375. PubMed ID: 34645392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
    Okumura Y; Noda T; Eguchi H; Sakamoto T; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2018 Nov; 25(12):3728-3737. PubMed ID: 30105440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
    Langenbecks Arch Surg; 2023 Nov; 408(1):445. PubMed ID: 37999810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
    Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
    World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.
    Chung MJ; Lee KJ; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB; Park JY
    Ann Surg Oncol; 2011 Jun; 18(6):1651-6. PubMed ID: 21210227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.